MS140, also known as XY028-140, is a cereblon-mediated PROTAC degrader targeting CDK4 and CDK6. Public sources describe it as a potent and selective CDK4/CDK6 degrader that reduces CDK4 and CDK6 protein levels and suppresses RB-E2F signaling, while detailed structural binding-site information remains limited in accessible summaries. In PROTAC design, the CDK-recognition element binds the kinase targets, the linker positions the degrader, and the cereblon ligand recruits CRL4-cereblon ubiquitination machinery. Mechanistically, MS140 induces proximity between CDK4 or CDK6 and cereblon, supporting ubiquitination and proteasome-dependent degradation of the kinases. It is useful for studying cell-cycle regulation, CDK4/CDK6 target validation, degradation versus kinase inhibition, selectivity among CDK-family proteins, and optimization of cereblon-recruiting kinase degraders that modulate RB-E2F pathway activity through protein depletion.
Structure of 2229974-83-6
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Target: MS140, also known as XY028-140, targets CDK4 and CDK6 kinases.
Binding site: Its CDK ligand binds the ATP-binding catalytic pockets of CDK4 and CDK6.
Mechanism of action: MS140 is a CRBN-mediated CDK4/6 PROTAC designed to degrade both CDK4 and CDK6 and thereby suppress RB-E2F pathway signaling through protein removal. The compound links a CDK4/6-recognition element to a cereblon-binding ligand, inducing formation of ternary complexes that promote ubiquitination of CDK4 and CDK6. Subsequent proteasomal degradation reduces target abundance in a dose- and time-dependent manner. MS140 is useful for studying cell-cycle control, degradation kinetics, CDK4 versus CDK6 contribution, and differences between CDK4/6 inhibitor exposure and degradation-mediated pathway suppression.
Applications• PROTAC-Mediated Targeted Degradation: MS140 is designed to facilitate the targeted degradation of specific proteins, offering researchers a powerful tool for probing protein function and validating therapeutic targets. By leveraging the ubiquitin-proteasome system, MS140 enables the selective removal of proteins, providing insights into cellular processes and disease mechanisms.
• Protein Interaction Studies: Utilizing MS140 in protein interaction studies allows researchers to dissect complex signaling pathways. By selectively degrading proteins of interest, MS140 aids in unraveling protein networks and interactions, enhancing the understanding of cellular dynamics and function.
• Drug Discovery and Development: MS140 serves as a pivotal asset in drug discovery, enabling the identification of novel therapeutic targets through targeted protein degradation. Its application in preclinical research accelerates the validation of potential drug candidates by elucidating the role of specific proteins in disease pathways.
• Mechanistic Pathway Analysis: Employing MS140 in mechanistic pathway analysis assists scientists in elucidating the functional roles of proteins within biological systems. By inducing protein degradation, MS140 provides a strategic approach to investigate cellular responses and regulatory mechanisms at a molecular level.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.